José Luis Fernández Puentes

Zeltia SA is a holding company, which develops marine-based drugs in the field of oncology. It operates through the Biopharmaceuticals and Consumer Chemicals segments. The Biopharmaceuticals segment engages in the research and marketing of anti-tumor drugs, diagnosis kits, and development of therapies based on reducing or silencing gene expression. The Consumer Chemicals segment produces and markets insecticides and air fresheners for household use, household products, wood treatment and decoration products, paints, and related products. The company was founded on August 3, 1939 and is headquartered in Madrid, Spain.

GENOMICA SAU provides genetic identification and molecular diagnostic services. Its services include paternity tests, fornsic genetics technological transfers and laboratory genetic identification for criminal investigation. The firm also offers various diagnostic kits and reagents such as CLART PneumoVir, CLINICAL ARRAYS Metabona and CLINICAL ARRAYS-Papillomavirus. It also provides laboratory installation and technical support services and training courses for laboratory, clinical and forensics professionals. The company was founded in 1990 and is headquartered in Madrid, Spain.

Antibióticos SA is a Spanish pharmaceutical company that specializes in manufacturing antibiotics and other pharmaceutical preparations. The company is based in León, Spain. Antibióticos was acquired by Black Toro Capital Partners (ES) from Grupo Enerthi on September 17, 2014 for $11.65 million.

Instituto Biomar SL is a biotechnology company engaged in the discovery and development of marine microorganisms. It also provides clients with research, assay screening, compound analysis, and DNA and RNA sequencing services. The company was founded by Jose Luis Fernandez Puente in 1996 and is headquartered in León, Spain.